Sustained Release Excipients Market Advances With Product Innovation Industry Trends Gaining Momentum in the Global Sustained Release Excipients Market

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Sustained Release Excipients Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
In recent times, the market size of sustained release excipients has seen significant growth. It's projected to increase from $1.4 billion in 2024 to $1.51 billion in 2025, exhibiting a Compound Annual Growth Rate (CAGR) of 8.1%. The past period's growth is linked to factors such as elevated demand for controlled drug release, prevalence of chronic illnesses, patient compliance and convenience, innovations in the pharmaceutical industry, and regulatory backing for extended-release formulations.

Sustained Release Excipients Market Size Forecast: What's the Projected Valuation by 2029?
The market size for sustained release excipients is projected to experience robust growth over the coming years. With an anticipated compound annual growth rate (CAGR) of 8.5%, it is expected to reach a value of $2.1 billion by 2029. The increase during the projection period can be associated with factors such as the growing elderly population, a focus on personalized healthcare, issues with patient adherence, the emergence of intricate drug formulations, advancements in handling diseases, and the enlargement of global healthcare. The pivotal trends likely to feature during this period encompass patient-oriented drug delivery, alliances for developing formulations, adherence to regulatory procedures and safety, worldwide development of drug formulation technologies, and the altering by biopharmaceuticals.

View the full report here:
https://www.thebusinessresearchcompany.com/report/sustained-release-excipients-global-market-report

What Are the Drivers Transforming the Sustained Release Excipients Market?
The growth of the sustained-release excipients market is anticipated to be fuelled by the rising incidence of chronic and acute illnesses. These are two separate categories used to categorize diseases based on their longevity and progression. Chronic conditions are enduring health issues that last for an extended duration, normally three months or longer. Acute ailments, on the other hand, manifest rapidly with severe but short-lived symptoms. These ailments arise abruptly and typically last a short time, ranging from a few hours to several days or weeks. Sustained-release excipients, which are widely utilized in the formulation of pharmaceutical products for both chronic and acute diseases, enhance patient compliance, stabilize drug levels, minimize adverse effects, and ameliorate disease management, thus boosting their sales. The World Health Organization (WHO), a Swiss health agency, reported in September 2022 that cardiovascular diseases led to the highest number of NCD deaths or 17.9 million people annually, followed by chronic respiratory diseases (4.1 million), diabetes (2 million, including kidney disease-related deaths due to diabetes), and cancer (9.3 million). Furthermore, in August 2022, the American College of Cardiology, a non-profit medical group in the United States, suggested that all four main cardiovascular risk factors will expand from 2025 to 2060, according to a study. Diabetes is forecasted to have the most significant percentage increase, with a 39.3% increase to 55 million people, followed by dyslipidemia (27.6% to 126 million), hypertension (25.1% to 162 million), and obesity (18.3% to 126 million). Additionally, substantial raises in stroke (33.8% to 15 million) and heart failure (33.4% to 13 million) rates are expected, with ischemic heart disease (30.7% to 29 million) and heart attack (16.9% to 16 million) closely following. Hence, the growing incidence of chronic and acute diseases is propelling the expansion of the sustained-release excipients market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10822&type=smp

What Are the Key Trends Driving Sustained Release Excipients Market Growth?
Product evolution is a prominent trend that's gaining attention in the sustained release excipients sector. Major enterprises in this market are producing inventive products to bolster their standing. For example, Nutriventia Limited, a pharmaceutical company based in India, introduced Prolanza, a sustained-release ingredient derived from ashwagandha (Withania somnifera), in September 2022. This advanced ashwagandha root-only extract provides ongoing support for stress reduction. The distinctive release mechanism of Prolanza allows for the exhibit of its therapeutic benefits over a prolonged duration with just a single daily dosage. Relative absorption and bioavailability are significantly improved with Prolanza ashwagandha, and it has a longer elimination half-life than the control component, indicating it has a sustained-release profile. Because ashwagandha is predominantly known for its ability to adapt and reduce stress responses, Prolanza's therapeutic effects will endure longer and exert a more beneficial impact on overall health. It's derived from natural herbs and its efficacy has been validated clinically.

Which Segments in the Sustained Release Excipients Market Offer the Most Profit Potential?
The sustained release excipients market covered in this report is segmented -

1) By Product: Gelatin, Polymers, Minerals, Sugars, Alcohol, Chitosan
2) By Route of Administration: Oral, Intramuscular, Subcutaneous, Transdermal, Vaginal, Ophthalmic, Intravenous, Other Routes of Administration
3) By Technology: Targeted Delivery, Micro Encapsulation, Wurster Technique, Transdermal, Implants, Coacervation

Subsegments:
1) By Gelatin: Type A Gelatin, Type B Gelatin
2) By Polymers: Natural Polymers, Synthetic Polymers
3) By Minerals: Calcium Compounds, Magnesium Compounds, Other Mineral Excipients
4) By Sugars: Sucrose, Lactose, Glucose, Other Sugars
5) By Alcohol: Ethanol, Isopropyl Alcohol, Other Alcohols
6) By Chitosan: Low Molecular Weight Chitosan, High Molecular Weight Chitosan

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=10822&type=smp

Which Firms Dominate the Sustained Release Excipients Market by Market Share and Revenue in 2025?
Major companies operating in the sustained release excipients market include BASF SE, Ashland Global Holdings Inc., Colorcon Inc., Croda International Plc, Dow Chemical Company, DuPont de Nemours Inc., Roquette Frères, Evonik Industries AG, Lubrizol Corporation, Merck KGaA, JRS Pharma GmbH & Co. KG, Shin-Etsu Chemical Co.Ltd., Gattefossé SAS, Eastman Chemical Company, Cellulose Solutions Private Limited, Avantor Inc., SPI Pharma Inc., Asahi Kasei Corporation, Chemische Fabrik Budenheim KG, Associated British Foods plc, Ransom Naturals Ltd, Balchem Corporation, IMCD Group, Lonza Group AG

Which Regions Offer the Highest Growth Potential in the Sustained Release Excipients Market?
North America was the largest region in the global sustained release excipients market in 2024.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sustained release excipients market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10822

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.